“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s95. Accessed October 31, 2025. https://skin.dermsquared.com/skin/article/view/1065.